Skip to main content
. 2013 Jan 8;14:3. doi: 10.1186/1471-2369-14-3

Table 2.

Data from the multicentric French cohort

  All patients Patients with normal platelets count Patients with thrombocytopenia P
Number of patients
107
14
93
 
Number of episodes
145
17
128
 
Number of relapsing patients
18 (20%)
2 (14%)
19 (20%)
0.88
Sex (%male)
29 (27%)
5 (36%)
24 (26%)
0.39
Age (years)
32 [22 – 45]
32 [22 – 45]
33 [23 – 42]
0.78
Biopsy proven TMA
72 (67%)
13 (93%)
59 (63%)
 
identification of mutation
75 (70%)
10 (71%)
65 (70%)
0.95
  CFH
40
6
34
 
  CFI
17
3
14
  MCP
10
1
9
  C3
11
1
10
  CFB
 
 
2
  Anti-factor H Autoantibody
 
 
2
Potential explanation
2 (13.3%)
1 (14.3%)
11 (12%)
  Familial form
 
1
10
  Low C3
2
0
1
Idiopathic
21 (23.3%)
3 (21.4%)
19 (25%)
Pregnancy associated HUS
19 (18%)
1 (7%)
17 (18%)
0.151
Platelets (G/L)*
79 [48-117]
214 [186 - 242]
68 [46-100]
< 0.001
Hb (g/dl)
7.2 [6,6 - 9]
8.6 [6.7-10]
7.2 [6.6 - 8.8]
0.16
LDH* (UI/L)
1688 [951-2930]
664 [498-1914]
1711 [999-1953]
0.017
Creatinine (mg/dl)
7.3 [4.1 - 11.3]
4.3 [2.6 - 12]
7.6 [4.6 - 11.3]
0.27
HD at the diagnosis
13 (12%)
1 (7%)
12 (13%)
0.68
HD during the episode
72 (80%)
10 (71%)
62 (81.6%)
0.6
Death Number/% 6 (6.7%) 1 (7.1%) 5 (6.6%) 0.9

For Numeric value, data are express in Median value [25%-75%], for categories, data are express in number of observation (%). Test used, Mann Whitney test (quantitative data) and Fisher's test for proportion and rate. Note, Conversion factors for units, serum creatinine in mg/dL to mol/L, ×88.4; serum urea nitrogen in mg/dL to mmol/L.